Pralsetinib

Gavreto

Kinase Inhibitor

NADAC/unit N/A

No Shortage Tier 1: 17.9% PA Req: 99.4%

Pralsetinib targets specific kinase enzymes involved in cancer cell growth and proliferation.

Covered Lives

Generic Manufacturers

RIGEL PHARMACEUTICALS INC

Explore in the Ecosystem

rxsaver.aiCompare prices for Pralsetinib drfinder.aiFind doctors who prescribe Pralsetinib rxpbm.aiPBM spread analysis for Pralsetinib clinicalrx.aiClinical profile: Pralsetinib

Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.